GSK (GSK) said Thursday it will stop setting diversity targets, citing US legal concerns amid President Donald Trump's executive orders rolling back federal diversity, equity, and inclusion programs.
The drugmaker said it has largely met past goals for improving ethnic and gender diversity in leadership.
GSK reaffirmed it is committed to an inclusive workplace but added that it will no longer pursue "aspirational targets" for leadership and supplier diversity.
"We expect to make changes in several areas related to inclusion, including no longer setting leadership aspirations," the company said in its annual report.
GSK shares were edging 0.2% lower in recent trading.
Price: 37.31, Change: -0.09, Percent Change: -0.24
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.